Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

ClinicalTrials.gov ID: NCT03711929

Public ClinicalTrials.gov record NCT03711929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LUMINA: A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.

Study identification

NCT ID
NCT03711929
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Santen Inc.
Industry
Enrollment
145 participants

Conditions and interventions

Interventions

  • DE-109 Intravitreal Injections Drug
  • Sham Procedure Other
  • DE-109 Intravitreal Injections (Open Label) Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2018
Primary completion
Jun 13, 2022
Completion
Jun 13, 2022
Last update posted
Dec 3, 2023

2018 – 2022

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Arizona Retina & Vitreous Consultants Phoenix Arizona 85021
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Kaiser Permanente Medical Center Los Angeles California 90027
USC Roski Eye Institute Los Angeles California 90032
Byers Eye Institute at Stanford Palo Alto California 94303
California Eye Specialist Medical Group, Inc. Pasadena California 91107
Colorado Retina Associates Golden Colorado 80401
Retina Vitreous Associates of Florida St. Petersburg Florida 33711
University of South Florida Eye Institute Tampa Florida 33612
Emory Eye Center Atlanta Georgia 30322
Marietta Eye Clinic Marietta Georgia 30060
Cook County Health & Hospitals System Chicago Illinois 60612
Illinois Retina Associate Oak Park Illinois 60304
Raj K.Maturi, MD Indianapolis Indiana 46290
University of Kansas School of Medicine Prairie Village Kansas 66208
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Ophthalmic Consultants of Boston Boston Massachusetts 02673
Kresge Eye Institute Detroit Michigan 48201
Associated Retina Consultants-Royal Oak Royal Oak Michigan 48073
Discover Vision Center Independence Missouri 64055
Eye Associates of New Mexico Albuquerque New Mexico 87109
New York Eye & Ear Infirmary of Mt. Sinai New York New York 10003
Wake Forest Baptist Medical Center/Surgery Winston-Salem North Carolina 27157
Cleveland Clinic Cole Eye Institute Cleveland Ohio 44195
Cascade Medical Research Institute, LLC Eugene Oregon 97401
Retina Vitreous Consultants Monroeville Pennsylvania 15146
Mid Atlantic Retina Philadelphia Pennsylvania 19107
UPMC Eye Center Pittsburgh Pennsylvania 15213
Vanderbilt Eye Institute Nashville Tennessee 37215
Austin Retina Associate Austin Texas 78705
Texas Retina Associates-Dallas-Main Dallas Texas 75231
Houston Eye Associates Houston Texas 77025
Retina Consultants of Houston Houston Texas 77030
Valley Retina Institute McAllen Texas 78503
Foresight Studies, San Antonio San Antonio Texas 78217
Medical Center Ophthalmology Associate San Antonio Texas 78240
Retina Group of Washington Fairfax Virginia 22031
West Virginia University Eye Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03711929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03711929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →